170 related articles for article (PubMed ID: 1683907)
1. Taxol: twenty years later, the story unfolds.
Rowinsky EK; Donehower RC
J Natl Cancer Inst; 1991 Dec; 83(24):1778-81. PubMed ID: 1683907
[No Abstract] [Full Text] [Related]
2. Taxol.
Lancet; 1992 Jun; 339(8807):1447-8. PubMed ID: 1351131
[No Abstract] [Full Text] [Related]
3. Clinical trials referral resource. Clinical trials with taxol.
Cheson BD
Oncology (Williston Park); 1992 Mar; 6(3):67-70. PubMed ID: 1348954
[No Abstract] [Full Text] [Related]
4. Taxol: an important new drug in the management of epithelial ovarian cancer.
Markman M
Yale J Biol Med; 1991; 64(6):583-90. PubMed ID: 1687343
[TBL] [Abstract][Full Text] [Related]
5. [Taxol and ovarian adenocarcinomas].
Marty M; Extra JM; Culine S; Rousseau F
Pathol Biol (Paris); 1992 Nov; 39(9):834-5. PubMed ID: 1347165
[No Abstract] [Full Text] [Related]
6. Taxol improves outlook for lung, breast, and ovarian cancer.
Oncology (Williston Park); 1992 Aug; 6(8):16. PubMed ID: 1354469
[No Abstract] [Full Text] [Related]
7. [Paclitaxel (taxol): a review of its antitumor activity and toxicity in clinical studies].
Yamazaki S; Sekine I; Saijo N
Gan To Kagaku Ryoho; 1998 Mar; 25(4):605-15. PubMed ID: 9530372
[TBL] [Abstract][Full Text] [Related]
8. Sequences of taxol and cisplatin: a phase I and pharmacologic study.
Rowinsky EK; Gilbert MR; McGuire WP; Noe DA; Grochow LB; Forastiere AA; Ettinger DS; Lubejko BG; Clark B; Sartorius SE
J Clin Oncol; 1991 Sep; 9(9):1692-703. PubMed ID: 1678780
[TBL] [Abstract][Full Text] [Related]
9. Dose-escalated paclitaxel in 1-hour infusion with a fixed dose of cisplatin in previously untreated advanced ovarian cancer: a phase II trial of the Spanish Group for Ovarian Cancer.
Cervantes A; Mendiola C; del Campo JM; Massuti B; Casado A; Escobedo A; Moyano A; Ojeda B; Poveda A; Benito D
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-40-S15-43. PubMed ID: 9346221
[TBL] [Abstract][Full Text] [Related]
10. Taxol in the management of cancers of the breast and the ovary.
Khayat D; Antoine EC; Coeffic D
Cancer Invest; 2000; 18(3):242-60. PubMed ID: 10754992
[No Abstract] [Full Text] [Related]
11. [Paclitaxel (Taxol)--drug of choice in ovarian cancer].
Fishman A
Harefuah; 1996 Apr; 130(8):557-60. PubMed ID: 8765885
[No Abstract] [Full Text] [Related]
12. Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study.
Skarlos DV; Aravantinos G; Kosmidis P; Athanassiadis A; Stathopoulos GP; Pavlidis N; Bafaloukos D; Karphathios S; Papakostas P; Bamia C; Fountzilas G
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-57-S15-61. PubMed ID: 9346224
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel as a component of initial chemotherapy of advanced ovarian cancer: is the controversy resolved.
Markman M
J Cancer Res Clin Oncol; 1998 Jan; 124(1):1-3. PubMed ID: 9498827
[No Abstract] [Full Text] [Related]
14. Taxol: a new agent active in melanoma and ovarian cancer.
Einzig AI; Wiernik PH; Schwartz EL
Cancer Treat Res; 1991; 58():89-100. PubMed ID: 1683787
[No Abstract] [Full Text] [Related]
15. Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms.
McGuire WP; Rowinsky EK; Rosenshein NB; Grumbine FC; Ettinger DS; Armstrong DK; Donehower RC
Ann Intern Med; 1989 Aug; 111(4):273-9. PubMed ID: 2569287
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel couplets with cyclophosphamide or cisplatin in metastatic breast cancer.
Tolcher AW
Semin Oncol; 1996 Feb; 23(1 Suppl 1):37-43. PubMed ID: 8629035
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer.
Holmes FA; Walters RS; Theriault RL; Forman AD; Newton LK; Raber MN; Buzdar AU; Frye DK; Hortobagyi GN
J Natl Cancer Inst; 1991 Dec; 83(24):1797-805. PubMed ID: 1683908
[TBL] [Abstract][Full Text] [Related]
18. Risks and benefits of taxanes in breast and ovarian cancer.
Michaud LB; Valero V; Hortobagyi G
Drug Saf; 2000 Nov; 23(5):401-28. PubMed ID: 11085347
[TBL] [Abstract][Full Text] [Related]
19. Hypertensive reactions associated with paclitaxel.
Solimando DA; Phillips ET; Weiss RB; Dawson NA; Diehl LF; Rickles NM
Cancer Invest; 1996; 14(4):340-2. PubMed ID: 8689429
[No Abstract] [Full Text] [Related]
20. Phase I trial of taxol given as a 24-hour infusion every 21 days: responses observed in metastatic melanoma.
Wiernik PH; Schwartz EL; Einzig A; Strauman JJ; Lipton RB; Dutcher JP
J Clin Oncol; 1987 Aug; 5(8):1232-9. PubMed ID: 2887641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
